Mitochondrial haplogroups -: Ischemic cardiovascular disease, other diseases, mortality, and longevity in the general population

被引:59
作者
Benn, Marianne [1 ]
Schwartz, Marianne [2 ]
Nordestgaard, Borge G. [3 ,4 ]
Tybjaerg-Hansen, Anne [1 ,4 ]
机构
[1] Univ Copenhagen, Fac Hlth Sci, Copenhagen Univ Hosp, Rigshosp,Dept Clin Biochem, Copenhagen, Denmark
[2] Univ Copenhagen, Fac Hlth Sci, Copenhagen Univ Hosp, Rigshosp,Dept Clin Genet, Copenhagen, Denmark
[3] Univ Copenhagen, Fac Hlth Sci, Herlev Univ Hosp, Dept Clin Biochem, Copenhagen, Denmark
[4] Univ Copenhagen, Fac Hlth Sci, Bispebjerg Univ Hosp, Copenhagen City Heart Study, Copenhagen, Denmark
关键词
cardiovascular diseases; cerebrovascular disorders; genetics; morbidity; mortality;
D O I
10.1161/CIRCULATIONAHA.107.756809
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Rare mutations in the mitochondrial genome may cause disease. Mitochondrial haplogroups defined by common polymorphisms have been associated with risk of disease and longevity. We tested the hypothesis that common haplogroups predict risk of ischemic cardiovascular disease, morbidity from other causes, mortality, and longevity in a general population of European descent. Methods and Results-We followed 9254 individuals from the Danish general population, in the Copenhagen City Heart Study, prospectively for risk of ischemic cardiovascular disease, morbidity from other causes, and mortality during 25 and 11 years, respectively. Haplogroup frequencies were as follows: H (45.9%), U (15.9%), T (9.9%), J (9.1), K (6.2%), V (4.5%), W/I (3.8%), and Z (3.5%). Hazard ratios for hospitalization due to all cardiovascular disorders (haplogroup U: 1.0 [95% confidence interval{CI}, 0.9 to 1.1]; T: 0.9 [95% CI, 0.8 to 1.0]; J: 1.0 [95% CI, 0.9 to 1.1]; K: 1.0 [95% CI, 0.9 to 1.2]; V: 1.0 [95% CI, 0.9 to 1.2]; W/I: 0.8 [95% CI, 0.7 to 1.0]; Z: 1.0 [95% CI, 0.8 to 1.2(), ischemic heart disease (U: 0.9 [95% CI, 0.8 to 1.1]; T: 0.9 [95% CI, 0.7 to 1.0]; J: 1.1 [95% CI, 0.9 to 1.2]; K: 1.1 [95% CI, 0.9 to 1.3]; V: 1.1 [95% CI, 0.9 to 1.4]; W/I: 1.1 [95% CI, 0.8 to 1.4]; Z: 1.1 [95% CI, 0.8 to 1.4]), and ischemic cerebrovascular disease (U: 1.1 [95% CI, 0.9 to 1.4]; T: 0.9 [95% CI, 0.7 to 1.2]; J: 1.1 [95% CI, 0.9 to 1.4]; K: 1.0 [95% CI, 0.8 to 1.4]; V: 1.1 [95% CI, 0.8 to 1.5]; W/ I: 0.8 [95% CI, 0.5 to 1.3]; Z: 0.9 [95% CI, 0.6 to 1.4]) did not differ from 1.0 for any haplogroup versus the most common haplogroup H. Results were similar for hospitalization due to infectious and parasitic diseases, respiratory infections, respiratory disorders, malignant neoplasms, digestive disorders, musculoskeletal disorders, neuropsychiatric disorders, and miscarriages. Likewise, hazard ratios for death from all causes were not different from 1.0 for any haplogroup versus haplogroup H (U: 1.0 [95% CI, 0.8 to 1.1]; T: 0.9 [95% CI, 0.8 to 1.1]; J: 0.9 [95% CI, 0.8 to 1.1]; K: 1.0 [95% CI, 0.8 to 1.2]; V: 1.1 [95% CI, 0.9 to 1.3]; W/ I: 0.8 [95% CI, 0.7 to 1.1]; Z: 0.9 [95% CI, 0.7 to 1.2]). Finally, after stratification by major causes of death, hazard ratios remained insignificant. Conclusions-Our results do not support an association of mitochondrial haplogroups with risk of ischemic cardiovascular disease, morbidity from other causes, mortality, or longevity in a large general population of European descent.
引用
收藏
页码:2492 / 2501
页数:10
相关论文
共 38 条
  • [1] North American white mitochondrial haplogroups in prostate and renal cancer
    Booker, LM
    Habermacher, GM
    Jessie, BC
    Sun, QC
    Baumann, AK
    Amin, M
    Lim, SD
    Fernandez-Golarz, C
    Lyles, RH
    Brown, MD
    Marshall, FF
    Petros, JA
    [J]. JOURNAL OF UROLOGY, 2006, 175 (02) : 468 - 472
  • [2] MITOCHONDRIAL-DNA AND HUMAN-EVOLUTION
    CANN, RL
    STONEKING, M
    WILSON, AC
    [J]. NATURE, 1987, 325 (6099) : 31 - 36
  • [3] Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women
    Canter, JA
    Kallianpur, AR
    Parl, FF
    Millikan, RC
    [J]. CANCER RESEARCH, 2005, 65 (17) : 8028 - 8033
  • [4] Re: North American white mitochondrial haplogroups in prostate and renal cancer
    Canter, Jeffrey A.
    Kallianpur, Asha R.
    Fowke, Jay H.
    [J]. JOURNAL OF UROLOGY, 2006, 176 (05) : 2308 - 2309
  • [5] Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO
  • [6] 2-K
  • [7] Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies
    Chinnery, PF
    Taylor, GA
    Howell, N
    Andrews, RM
    Morris, CM
    Taylor, RW
    McKeith, IG
    Perry, RH
    Edwardson, JA
    Turnbull, DM
    [J]. NEUROLOGY, 2000, 55 (02) : 302 - 304
  • [8] A population-based study of morbidity and mortality in mannose-binding lectin deficiency
    Dahl, M
    Tybjærg, A
    Schnohr, P
    Nordestgaard, BG
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (10) : 1391 - 1399
  • [9] Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans
    De Benedictis, G
    Rose, G
    Carrieri, G
    De Luca, M
    Falcone, E
    Passarino, G
    Bonafé, M
    Monti, D
    Baggio, G
    Bertolini, S
    Mari, D
    Mattace, R
    Franceschi, C
    [J]. FASEB JOURNAL, 1999, 13 (12) : 1532 - 1536
  • [10] Mechanisms of disease: Mitochondrial respiratory-chain diseases
    DiMauro, S
    Schon, EA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (26) : 2656 - 2668